Journal of Pharmaceutical Investigation

, Volume 48, Issue 2, pp 187–197 | Cite as

Bone morphogenetic protein-2 associated multiple growth factor delivery for bone tissue regeneration

  • Joon Park
  • Sungjun Kim
  • Kyobum KimEmail author


Administration of growth factors (GFs) and cytokines to damaged bone tissue for the purpose of bone tissue regeneration has been investigated. Among GFs and cytokines, bone morphogenetic protein-2 (BMP-2) is one of the most important stimulatory factors for enhancing the osteoblastic differentiation of progenitor cells and promoting bone formation. Co-delivery of other GFs, including vascular endothelial growth factor, fibroblast growth factor, insulin-like growth factor, and stromal cell-derived factor, with BMP-2 is known to facilitate repair and remodeling of damaged bone tissue. These GFs stimulate various cellular activities, including angiogenesis, migration, proliferation, regulation of proteoglycan level, and stem cell recruitment. Although bone repair and regeneration are dynamic and complex physiological processes involving multiple cell types and cytokines in timed healing cascade stages, BMP-2-associated delivery of dual and/or multiple GFs could promote bone tissue regeneration based on the synergistic effects of GFs compared with single GF treatment. Current engineering approaches emphasize the importance of design parameters for GF delivery systems, such as optimization of the release profiles, stabilities, and bioactivities of cargo GFs, and the physico-chemical properties of scaffold/hydrogel materials. Therefore, this review summarizes BMP-2-associated GF combinations, biological functions, and current delivery strategies utilized in bone tissue engineering for the development of feasible clinical applications.


Bone morphogenetic protein-2 Dual growth factor delivery Bone regeneration Tissue engineering 



The research was supported by National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2017R1C1B1003665) and Nano Material Technology Development Program through NRF funded by the Ministry of Science and ICT (No. 2017M3A7B8061942).

Compliance with ethical standards

Conflict of interest

All authors (J. Park, S. Kim, and K. Kim) declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human or animal subjects performed by any of the authors.


  1. Barati D, Shariati SRP, Moeinzadeh S, Melero-Martin JM, Khademhosseini A, Jabbari E (2016) Spatiotemporal release of BMP-2 and VEGF enhances osteogenic and vasculogenic differentiation of human mesenchymal stem cells and endothelial colony-forming cells co-encapsulated in a patterned hydrogel. J Control Release 223:126–136CrossRefGoogle Scholar
  2. Charles LF, Woodman JL, Ueno D, Gronowicz G, Hurley MM, Kuhn LT (2015) Effects of low dose FGF-2 and BMP-2 on healing of calvarial defects in old mice. Exp Gerontol 64:62–69CrossRefGoogle Scholar
  3. Chen FM, Chen R, Wang XJ, Sun HH, Wu ZF (2009) In vitro cellular responses to scaffolds containing two microencapulated growth factors. Biomaterials 30(28):5215–5224CrossRefGoogle Scholar
  4. Chen FM, Zhang M, Wu ZF (2010) Toward delivery of multiple growth factors in tissue engineering. Biomaterials 31(24):6279–6308CrossRefGoogle Scholar
  5. Christopoulos PF, Msaouel P, Koutsilieris M (2015) The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer 14:43CrossRefGoogle Scholar
  6. Clemmons DR (2004) The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J Clin Invest 113(1):25–27CrossRefGoogle Scholar
  7. Davis DA, Singer KE, Sierra MD, Narazaki M, Yang FQ, Fales HM, Yarchoan R, Tosato G (2005) Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1 alpha in the circulation. Blood 105(12):4561–4568CrossRefGoogle Scholar
  8. Egri S, Eczacioglu N (2017) Sequential VEGF and BMP-2 releasing PLA-PEG-PLA scaffolds for bone tissue engineering: I. design and in vitro tests. Artif Cells Nanomed Biotechnol 45(2):321–329CrossRefGoogle Scholar
  9. Fujioka-Kobayashi M, Ota MS, Shimoda A, Nakahama K, Akiyoshi K, Miyamoto Y, Iseki S (2012) Cholesteryl group- and acryloyl group-bearing pullulan nanogel to deliver BMP2 and FGF18 for bone tissue engineering. Biomaterials 33(30):7613–7620CrossRefGoogle Scholar
  10. Gajendiran M, Rhee JS, Kim K (2017). Recent developments in thiolated polymeric hydrogels for tissue engineering applications. Tissue Eng Part B Rev. CrossRefPubMedGoogle Scholar
  11. Giannoudis PV, Dinopoulos H, Tsiridis E (2005). Bone substitutes: an update. Injury 36(Suppl 3):S20–S27CrossRefGoogle Scholar
  12. Ginty PJ, Barry JJA, White LJ, Howdle SM, Shakesheff KM (2008) Controlling protein release from scaffolds using polymer blends and composites. Eur J Pharm Biopharm 68(1):82–89CrossRefGoogle Scholar
  13. Glowacki J (1998). Angiogenesis in fracture repair. Clin Orthop Relat Res (355 Suppl):S82–S89Google Scholar
  14. Goodrich JT, Sandler AL, Tepper O (2012) A review of reconstructive materials for use in craniofacial surgery bone fixation materials, bone substitutes, and distractors. Childs Nerv Syst 28(9):1577–1588CrossRefGoogle Scholar
  15. Gronowicz G, Hurley MM, Kuhn LT (2014) Optimizing BMP-2-induced bone repair with FGF-2. J Am Acad Orthop Surg 22(10):677–679CrossRefGoogle Scholar
  16. Gronowicz G, Jacobs E, Peng T, Zhu L, Hurley M, Kuhn LT (2017). Calvarial bone regeneration is enhanced by sequential delivery of FGF-2 and BMP-2 from layer-by-layer coatings with a biomimetic calcium phosphate barrier layer. Tissue Eng Part A 23:1490–1501CrossRefGoogle Scholar
  17. Herberg S, Kondrikova G, Periyasamy-Thandavan S, Howie RN, Elsalanty ME, Weiss L, Campbell P, Hill WD, Cray JJ (2014a) Inkjet-based biopatterning of SDF-1 beta augments BMP-2-induced repair of critical size calvarial bone defects in mice. Bone 67:95–103CrossRefGoogle Scholar
  18. Herberg S, Susin C, Pelaez M, Howie RN, Moreno de Freitas R, Lee J, Cray JJ Jr, Johnson MH, Elsalanty ME, Hamrick MW, Isales CM, Wikesjo UM, Hill WD (2014b) Low-dose bone morphogenetic protein-2/stromal cell-derived factor-1beta cotherapy induces bone regeneration in critical-size rat calvarial defects. Tissue Eng Part A 20(9–10):1444–1453CrossRefGoogle Scholar
  19. Hosogane N, Huang Z, Rawlins BA, Liu X, Boachie-Adjei O, Boskey AL, Zhu W (2010) Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int J Biochem Cell Biol 42(7):1132–1141CrossRefGoogle Scholar
  20. Hwang HD, Lee JT, Koh JT, Jung HM, Lee HJ, Kwon TG (2015) Sequential Treatment with SDF-1 and BMP-2 Potentiates Bone Formation in Calvarial Defects. Tissue Eng Part A 21(13–14):2125–2135CrossRefGoogle Scholar
  21. James AW, LaChaud G, Shen J, Asatrian G, Nguyen V, Zhang X, Ting K, Soo C (2016) A review of the clinical side effects of bone morphogenetic protein-2. Tissue Eng Part B Rev 22(4):284–297CrossRefGoogle Scholar
  22. Kaewsrichan J, Wongwitwichot P, Chandarajoti K, Chua KH, Ruszymah BHI (2011) Sequential induction of marrow stromal cells by FGF2 and BMP2 improves their growth and differentiation potential in vivo. Arch Oral Biol 56(1):90–101CrossRefGoogle Scholar
  23. Kanczler JM, Ginty PJ, White L, Clarke NM, Howdle SM, Shakesheff KM, Oreffo RO (2010) The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 31(6):1242–1250CrossRefGoogle Scholar
  24. Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJ (2009) Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30(14):2816–2825CrossRefGoogle Scholar
  25. Kim K, Dean D, Mikos AG, Fisher JP (2009) Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks. Biomacromol 10(7):1810–1817CrossRefGoogle Scholar
  26. Kim K, Yeatts A, Dean D, Fisher JP (2010) Stereolithographic bone scaffold design parameters: osteogenic differentiation and signal expression. Tissue Eng Part B Rev 16(5):523–539CrossRefGoogle Scholar
  27. Kim K, Dean D, Lu A, Mikos AG, Fisher JP (2011a) Early osteogenic signal expression of rat bone marrow stromal cells is influenced by both hydroxyapatite nanoparticle content and initial cell seeding density in biodegradable nanocomposite scaffolds. Acta Biomater 7(3):1249–1264CrossRefGoogle Scholar
  28. Kim K, Dean D, Wallace J, Breithaupt R, Mikos AG, Fisher JP (2011b) The influence of stereolithographic scaffold architecture and composition on osteogenic signal expression with rat bone marrow stromal cells. Biomaterials 32(15):3750–3763CrossRefGoogle Scholar
  29. Kim S, Kang YQ, Krueger CA, Sen ML, Holcomb JB, Chen D, Wenke JC, Yang YZ (2012) Sequential delivery of BMP-2 and IGF-1 using a chitosan gel with gelatin microspheres enhances early osteoblastic differentiation. Acta Biomater 8(5):1768–1777CrossRefGoogle Scholar
  30. Kim K, Lam J, Lu S, Spicer PP, Lueckgen A, Tabata Y, Wong ME, Jansen JA, Mikos AG, Kasper FK (2013) Osteochondral tissue regeneration using a bilayered composite hydrogel with modulating dual growth factor release kinetics in a rabbit model. J Controlled Release 168(2):166–178CrossRefGoogle Scholar
  31. Kneser U, Schaefer DJ, Polykandriotis E, Horch RE (2006) Tissue engineering of bone: the reconstructive surgeon’s point of view. J Cell Mol Med 10(1):7–19CrossRefGoogle Scholar
  32. Kuhn LT, Ou GM, Charles L, Hurley MM, Rodner CM, Gronowicz G (2013) Fibroblast growth factor-2 and bone morphogenetic protein-2 have a synergistic stimulatory effect on bone formation in cell cultures from elderly mouse and human bone. J Gerontol Series a-Biol Sci Med Sci 68(10):1170–1180CrossRefGoogle Scholar
  33. Lam J, Kim K, Lu S, Tabata Y, Scott DW, Mikos AG, Kasper FK (2014a) A factorial analysis of the combined effects of hydrogel fabrication parameters on the in vitro swelling and degradation of oligo(poly(ethylene glycol) fumarate) hydrogels. J Biomed Mater Res Part A 102(10):3477–3487CrossRefGoogle Scholar
  34. Lam J, Lu S, Lee EJ, Trachtenberg JE, Meretoja VV, Dahlin RL, van den Beucken JJJP., Tabata Y, Wong ME, Jansen JA, Mikos AG, Kasper FK (2014b) Osteochondral defect repair using bilayered hydrogels encapsulating both chondrogenically and osteogenically pre-differentiated mesenchymal stem cells in a rabbit model. Osteoarthritis Cartilage 22(9):1291–1300CrossRefGoogle Scholar
  35. Laron Z (2001) Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol Pathol 54(5):311–316CrossRefGoogle Scholar
  36. Lee K, Silva EA, Mooney DJ (2011) Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface 8(55):153–170CrossRefGoogle Scholar
  37. Lee CH, Jin MU, Jung HM, Lee JT, Kwon TG (2015). Effect of dual treatment with SDF-1 and BMP-2 on ectopic and orthotopic bone formation. PLoS ONE 10(3):e0120051CrossRefGoogle Scholar
  38. Lei L, Wang S, Wu HH, Ju W, Peng J, Qahtan ASA, Chen C, Lu YQ, Peng JY, Zhang X, Nie HM (2015) Optimization of release pattern of FGF-2 and BMP-2 for osteogenic differentiation of low-population density hMSCs. J Biomed Mater Res Part A 103(1):252–261CrossRefGoogle Scholar
  39. Liu Y, Deng LZ, Sun HP, Xu JY, Li YM, Xie X, Zhang LM, Deng FL (2016) Sustained dual release of placental growth factor-2 and bone morphogenic protein-2 from heparin-based nanocomplexes for direct osteogenesis. Int J Nanomed 11:1147–1158CrossRefGoogle Scholar
  40. Lohse N, Moser N, Backhaus S, Annen T, Epple M, Schliephake H (2015) Continuous delivery of rhBMP2 and rhVEGF165 at a certain ratio enhances bone formation in mandibular defects over the delivery of rhBMP2 alone—an experimental study in rats. J Controlled Release 220:201–209CrossRefGoogle Scholar
  41. Lou E (2001). Bone morphogenetic proteins: an overview of therapeutic applications. Orthopedics. 24(5):504–509 (quiz 510–501)PubMedGoogle Scholar
  42. Lu S, Lam J, Trachtenberg JE, Lee EJ, Seyednejad H, van den Beucken JJ, Tabata Y, Wong ME, Jansen JA, Mikos AG, Kasper FK (2014) Dual growth factor delivery from bilayered, biodegradable hydrogel composites for spatially-guided osteochondral tissue repair. Biomaterials 35(31):8829–8839CrossRefGoogle Scholar
  43. Marquez-Curtis L, Jalili A, Deiteren K, Shirvaikar N, Lambeir AM, Janowska-Wieczorek A (2008) Carboxypeptidase M expressed by human bone marrow cells cleaves the C-terminal lysine of stromal cell-derived factor-1 alpha: another player in hematopoietic stem/progenitor cell mobilization? Stem Cells 26(5):1211–1220CrossRefGoogle Scholar
  44. Morell CM, Fabris L, Strazzabosco M (2013) Vascular biology of the biliary epithelium. J Gastroenterol Hepatol 28(Suppl 1):26–32CrossRefGoogle Scholar
  45. Patel ZS, Young S, Tabata Y, Jansen JA, Wong ME, Mikos AG (2008) Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43(5):931–940CrossRefGoogle Scholar
  46. Peng HR, Usas A, Olshanski A, Ho AM, Gearhart B, Cooper GM, Huard J (2005) VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20(11):2017–2027CrossRefGoogle Scholar
  47. Raiche AT, Puleo DA (2004) In vitro effects of combined and sequential delivery of two bone growth factors. Biomaterials 25(4):677–685CrossRefGoogle Scholar
  48. Ramazanoglu M, Lutz R, Rusche P, Trabzon L, Kose GT, Prechtl C, Schlegel KA (2013) Bone response to biomimetic implants delivering BMP-2 and VEGF: an immunohistochemical study. J Craniomaxillofac Surg 41(8):826–835CrossRefGoogle Scholar
  49. Ratanavaraporn J, Furuya H, Kohara H, Tabata Y (2011) Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration. Biomaterials 32(11):2797–2811CrossRefGoogle Scholar
  50. Schliephake H, Weich HA, Dullin C, Gruber R, Frahse S (2008) Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid—an experimental study in rats. Biomaterials 29(1):103–110CrossRefGoogle Scholar
  51. Schmidt MB, Chen EH, Lynch SE (2006) A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage 14(5):403–412CrossRefGoogle Scholar
  52. Song I, Kim BS, Kim CS, Im GI (2011) Effects of BMP-2 and vitamin D3 on the osteogenic differentiation of adipose stem cells. Biochem Biophys Res Commun 408(1):126–131CrossRefGoogle Scholar
  53. Springer IN, Niehoff P, Acil Y, Marget M, Lange A, Warnke PH, Pielenz H, Roldan JC, Wiltfang J (2008) BMP-2 and bFGF in an irradiated bone model. J Craniomaxillofac Surg 36(4):210–217CrossRefGoogle Scholar
  54. Sun HP, Wang JM, Deng FL, Liu Y, Zhuang XM, Xu JY, Li L (2016) Co-delivery and controlled release of stromal cell-derived factor-1 alpha chemically conjugated on collagen scaffolds enhances bone morphogenetic protein-2-driven osteogenesis in rats. Mol Med Rep 14(1):737–745CrossRefGoogle Scholar
  55. Tan LL, Yu XM, Wan P, Yang K (2013) Biodegradable materials for bone repairs: a review. J Mater Sci Technol 29(6):503–513CrossRefGoogle Scholar
  56. Wang HN, Zou Q, Boerman OC, Nijhuis AWG, Jansen JA, Li YB, Leeuwenburgh SCG (2013) Combined delivery of BMP-2 and bFGF from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivo. J Controlled Release 166(2):172–181CrossRefGoogle Scholar
  57. Wang Y, Wei Y, Zhang XH, Xu MM, Liu F, Ma Q, Cai Q, Deng XL (2015) PLGA/PDLLA core-shell submicron spheres sequential release system: preparation, characterization and promotion of bone regeneration in vitro and in vivo. Chem Eng J 273:490–501CrossRefGoogle Scholar
  58. Wozney JM (2002) Overview of bone morphogenetic proteins. Spine 27(16 Suppl 1):S2–S8CrossRefGoogle Scholar
  59. Zhang WJ, Wang XL, Wang SY, Zhao J, Xu LY, Zhu C, Zeng DL, Chen J, Zhang ZY, Kaplan DL, Jiang XQ (2011) The use of injectable sonication-induced silk hydrogel for VEGF(165) and BMP-2 delivery for elevation of the maxillary sinus floor. Biomaterials 32(35):9415–9424CrossRefGoogle Scholar
  60. Zhang W, Zhu C, Wu Y, Ye D, Wang S, Zou D, Zhang X, Kaplan DL, Jiang X (2014) VEGF and BMP-2 promote bone regeneration by facilitating bone marrow stem cell homing and differentiation. Eur Cell Mater 27:1–11 (discussion 11–12)CrossRefGoogle Scholar
  61. Zhao W, Jin K, Li J, Qiu X, Li S (2017) Delivery of stromal cell-derived factor 1alpha for in situ tissue regeneration. J Biol Eng 11:22CrossRefGoogle Scholar
  62. Zwingenberger S, Langanke R, Vater C, Lee G, Niederlohmann E, Sensenschmidt M, Jacobi A, Bernhardt R, Muders M, Rammelt S, Knaack S, Gelinsky M, Gunther KP, Goodman SB, Stiehler M (2016) The effect of SDF-1alpha on low dose BMP-2 mediated bone regeneration by release from heparinized mineralized collagen type I matrix scaffolds in a murine critical size bone defect model. J Biomed Mater Res A 104(9):2126–2134CrossRefGoogle Scholar

Copyright information

© The Korean Society of Pharmaceutical Sciences and Technology 2018

Authors and Affiliations

  1. 1.Department of BiotechnologyKorea University Graduate SchoolSeoulSouth Korea
  2. 2.Division of Functional Food ResearchKorea Food Research InstituteJeonjuSouth Korea
  3. 3.Division of Bioengineering, College of Life Sciences and BioengineeringIncheon National UniversityIncheonSouth Korea

Personalised recommendations